AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is tanking heavily in the pre-market hours today, and for good reason. The company announced minutes ago that it plans on moving forward with a public offering. While this type of news generally leads to concern, the declines caused by today’s news may actually be an opportunity. Today, we’ll talk … Read more
Recently, AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has been seeing gains in the market, and for good reason. The company recently announced that its painkiller, Dsuvia has been approved by the FDA. However, the stock is tanking today with no news released by the company? What’s the deal? Well, it has to do with the opiod … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) could see some very strong times ahead, and for good reason. While the company reported an earnings report that missed the mark on Friday, something else happened that made it so that investors weren’t concerned. The company received FDA approval for Dsuvia, an incredibly powerful pain killer. Today, we’ll talk … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an incredibly strong start to the trading session this morning, but if you’re looking for press releases or SEC filings, you’re not going to find anything issued today. Nonetheless, we believe that we know the reason for the gains. Today, we’ll talk about: Why ACRX stock is headed … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has been all over the place this morning. Early in the pre-market, the stock was trading deep in the red. Right now, it’s slightly in the green. But with no press releases or SEC filings, many are wondering what’s going on. Today, we’ll talk about: Why ACRX is trading irradically; … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having a great start to the trading session this morning, and for good reason. The company announced European approval of one of its treatments. Of course, the news proved to excite investors, sending the stock screaming for the top. Today, we’ll talk about: The approval; what we’re seeing from … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an incredibly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced the acceptance of an NDA resubmission by the FDA. Of course, the news excited investors, sending the stock on a tear for the top. Today, we’ll talk … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an overwhelmingly strong start to the trading session this morning after the company announced that shares owned by Three Arch Partners have been acquired in a private deal. Of course, the news led to excitement among investors, sending the stock upward. Today, we’ll talk about: The share acquisition; … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an overwhelmingly rough day in the market today, and for good reason. The United States Food and Drug Administration (FDA) has rejected the company’s painkilling drug. Of course, this is causing fear among investors, sending the stock spiraling down to the bottom. As is normally the case, our … Read more
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is having an incredibly strong day in the market today, and for good reason. A Seeking Alpha contributor wrote an article about the company, bringing a massive coming catalyst to light and causing excitement among investors. Of course, this led to gains in the stock, prompting our friends at Trade … Read more